Business Wire (Wed, 8:02AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,036 people get ZTS articles and Market Currents by email alert.
Get email alerts on ZTS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 16, 2013)
-
Business Wire (Apr 30, 2013)
-
-
-
-
-
Business Wire (Mar 28, 2013)
-
Business Wire (Mar 26, 2013)
-
-
-
-
-
-
-
-
-
-
Business Wire (Feb 6, 2013)
To learn more about Seeking Alpha Pro, click here.
-
at CNBC.com (Wed, 4:08PM)
-
at Fox Business (Wed, 10:13AM)
-
Business Wire (Wed, 8:02AM)
-
at Fox Business (Wed, 7:27AM)
-
Business Wire (May 16, 2013)
-
at MarketWatch.com (May 13, 2013)
-
at Fox Business (May 2, 2013)
-
at CNBC.com (May 2, 2013)
-
at CNBC.com (Apr 30, 2013)
-
Business Wire (Apr 30, 2013)
-
at CNBC.com (Apr 26, 2013)
-
Business Wire (Mar 28, 2013)
-
Business Wire (Mar 26, 2013)
-
at CNBC.com (Feb 20, 2013)
-
at CNBC.com (Feb 6, 2013)
-
Business Wire (Feb 6, 2013)
-
at CNBC.com (Feb 6, 2013)
-
at MarketWatch.com (Feb 4, 2013)
-
at MarketWatch.com (Feb 1, 2013)
-
at Fox Business (Feb 1, 2013)
ZTS vs. ETF Alternatives
Company Description
Zoetis is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. For more than 60 years, as a business unit of Pfizer, we have been committed to enhancing the health of... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, May 22, 8:18 AM Pfizer (PFE) plans to spin off its remaining stake in Zoetis (ZTS) through a tax-free exchange offer in which Pfizer owners can exchange their Pfizer shares for stock in Zoetis owned by Pfizer (got that?). Pfizer has received a waiver of the 180-day lock-up from the book runners of the Zoetis IPO. PFE +2.1%, ZTS -1.2% premarket. (PR) 9 Comments [Healthcare, Breaking News, On the Move]
- Tuesday, April 30, 7:10 AM Zoetis (ZTS): Q1 EPS of $0.36 beats by $0.03. Revenue of $1.09B (+4% Y/Y) misses by $0.15B. (PR) Comment! [Earnings, Breaking News, Consumer]
- Thursday, March 28, 6:10 PM Zoetis (ZTS) declares $0.065/share quarterly dividend. Forward yield 0.77%. For shareholders of record May 01. Payable June 06. Ex-div date Apr. 29. (PR) Comment! [Dividends]
- Sunday, February 3, 3:18 AM Pfizer (PFE) animal-health spin-off Zoetis (ZTS) forecasts annual growth of 5.7% through 2016, CEO Juan Ramon Alaix tells Bloomberg. He points out that drug failure rates are lower than with human medicines, as there are fewer safety concerns and because animals don't live as long. "Side effects are very rare in our industry, especially in livestock," Alaix says. Zoetis had a stonking NYSE debut on Friday, jumping 19% to close at $31.01 for a market cap of $15.51B. 1 Comment [Healthcare, On the Move]
- Friday, February 1, 10:22 AM Zoetis (ZTS) opens at $31.50, rising 21% from its $26 initial pricing last night - which had already been priced above the expected range of $22 to $25 due to high demand. The animal nutrition spinoff from Pfizer (PFE) raised $2.2B, making it the largest IPO from a U.S. firm since Facebook. 3 Comments [Healthcare, On the Move]
- Friday, February 1, 9:50 AM Pfizer's (PFE) animal-health spinoff, Zoetis (ZTS) is indicated to open in the $30-$32 range after pricing at $26 last night. Pfizer retains an 80% stake in the company. 2 Comments [Healthcare, Breaking News, On the Move]
- Thursday, January 31, 5:58 PM Pfizer's (PFE) animal health spin-off, Zoetis (ZTS) prices its IPO at $26 per share, above the expected $22 - $25 range. Shares are expected to begin trading on the NYSE on Friday. 12 Comments [Healthcare]